Ciclotizolam
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2-Bromo-4-(o-chlorophenyl)-9-cyclohexyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 58765-21-2 |
| ATC code | None |
| PubChem | CID 71949 |
| ChemSpider | 64956 |
| UNII | JK517QTN4Q |
| Chemical data | |
| Formula | C20H18BrClN4S |
| Mol. mass | 461.806 |
|
|
|
|
| |
|
Ciclotizolam[1] (WE-973) is a drug which is a thienobenzodiazepine derivative. It is a partial agonist for the benzodiazepine site of the GABAA receptor, with similar binding affinity to related compounds like brotizolam, but a low efficacy.[2][3]
See also [edit]
References [edit]
- ^ DE Patent 2445430
- ^ Weber KH, Kuhn FJ, Böke-Kuhn K, Lehr E, Danneberg PB, Hommer D, Paul SM, Skolnick P (February 1985). "Pharmacological and neurochemical properties of 1,4-diazepines with two annelated heterocycles ('hetrazepines')". European Journal of Pharmacology 109 (1): 19–31. doi:10.1016/0014-2999(85)90535-7. PMID 2986988.
- ^ Ikeda M, Weber KH, Bechtel WD, Malatynska E, Yamamura HI (1989). "Relative efficacies of 1,4-diazepines on GABA-stimulated chloride influx in rat brain vesicles". Life Sciences 45 (4): 349–58. doi:10.1016/0024-3205(89)90145-8. PMID 2569655.
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |